Dublin, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Flow Cytometry Market 2016-2020" report to their offering. The analysts forecast the global flow cytometry market to grow at a CAGR of 9.84% during the period 2016-2020. The report covers the present scenario and the growth prospects of the global flow cytometry market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of instruments, reagents, and services provided for flow cytometry process. The report also includes a discussion of the key vendors operating in this market.
Increased use of multiplex-based assays will be a key trend for market growth. In clinical diagnostics and research, the analysis of serum and plasma is of prime importance for which researchers need precise yet rapid and cost-effective measurement for analysis and interpretation. Multiplex bead array assays provide quantitative analysis of large numbers of analytes. BD Cytometric Beads, for instance, allow researchers to quantify multiple proteins simultaneously. The BD CBA system also involves a wide range of fluorescence detection capabilities offered by flow cytometry and antibody-coated beads, which have the ability to efficiently capture analytes. Each bead in the array incorporates a unique fluorescence intensity for the simultaneous analysis of beads. This requires less time for analysis than traditional technologies such as ELISA and Western blotting. According to the report, one of the key drivers for market growth will be technological advances. Flow cytometry devices have a wide range of applications in a number of areas that include immunology, pathology, molecular biology, marine biology, and plant biology. The increase in research on monoclonal antibodies and molecular diagnostics and improved understanding of immunologic factors that regulate systemic diseases have a strong impact on the growth of this market over the past five years. Technological advances have led to the development of much more effective fluorogenic markets and reagents. Further, the report states that flow cytometry instruments are extremely expensive and require a large initial investment to procure, set up, and calibrate. Apart from the rather large initial investment that goes into these instruments, the reagents, markers, and other consumables that are required for the process for detection, apart from the software support needed to obtain quantifiable results, are also rather expensive. This translates to a high TCO (total cost of ownership) for the user. The high cost of this process will tend to be a challenge to the adoption of this technology in the healthcare and pharmaceutical sectors.
Key vendors
- Beckman Coulter
- BD
- EMD Millipore
- Luminex
- Thermo Fisher Scientific
Other prominent vendors
- Advanced Analytical Technologies
- Apogee Flow Systems
- Bio-Rad Laboratories
- Cytek Biosciences
- Cytonome
- Miltenyi Biotec
- Mindray Medical
- Sysmex Partec
- Sony Biotechnology
- Stratedigm
- TTP Labtech
For more information about this report visit http://www.researchandmarkets.com/research/cv...lobal_flow
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Biotechnology
